Study ‘offers new insight’ on neuropathogenesis of COVID-19
If confirmed, the findings would have implications for the treatment of patients, researchers say
SARS-CoV-2 viral antigens may contribute to central nervous system immune responses without direct viral invasion of the CNS, new data suggest.
It is now known that patients with COVID-19 may develop neurologic symptoms but it is unclear why, as SARS-CoV-2 RNA is rarely detected in CSF, researchers say.
